skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Preparation and biodistribution of 1-(2-(3-(/sup 125/I)iodo-4-aminophenyl)ethyl)-4-(3-(trifluoromethyl) phenyl)piperazine and 1-(2-(3-(/sup 125/I)iodo-4-azidophenyl)ethyl)-4-(3-(trifluoromethyl)phenyl) piperazine

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00123a006· OSTI ID:6075270

The iodinated analogue of 1-(2-(4-aminophenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)piperazine (PAPP), IPAPP (4), and the corresponding azido compound azido-IPAPP (5) were synthesized. The corresponding no-carrier-added /sup 125/I (T1/2 = 60 days, 35-60 keV) labeled compounds were also prepared. High specific binding was observed from in vitro binding studies using rat brain tissue preparation; Ki = 20 and 17.5 nM against (/sup 3/H)-5-HT. In vivo biodistribution studies in rats showed that azido-(/sup 125/I)IPAPP passed through intact blood-brain barrier and localized in the brain. Ex vivo autoradiography of rat brain sections exhibited a diffuse uptake pattern, which may be due to specific and nonspecific binding. The results indicate that IPAPP and azido-IPAPP may not be suitable to image the serotonin receptor in the brain.

Research Organization:
Univ. of Pennsylvania, Philadelphia (USA)
OSTI ID:
6075270
Journal Information:
J. Med. Chem.; (United States), Vol. 32:3
Country of Publication:
United States
Language:
English